Table 2. Clinical characteristics of patients with HCC.

Patient	Age	Gender	Tumor size (cm)	Differentiation status	Serum LECT2 level (ng/mL)	Mutation	RNA available
K284	81	M	4.1	Well	93.2	WT	○
K285	64	M	1.7	Well	87.9	WT	×
K286	69	F	4.9	Moderate	48.7	WT	○
K287	62	M	1.6	Well	62.6	WT	○
K288	63	M	1.7	Well	52.6	WT	○
K289	58	M	3.8	Moderate	83.3	WT	×
K290	77	M	1.5	Moderate	64.6	WT	○
K291	52	M	7.8	Moderate	63.4	WT	○
K293	39	M	2.0	Moderate	69.3	WT	○
K294	36	M	2.5	Moderate	32.8	WT	×
K295	74	M	4.0	Moderate	78.2	WT	○
K296	76	M	2.4	Moderate	46.9	WT	○
K297	70	M	4.4	Necrosis (TACE)	95.1	WT	×
K298	66	M	4.3	Moderate	54.4	WT	×
K299	67	M	2.5	Moderate	61.3	WT	○
K300	74	F	5.5	Moderate	32.8	WT	×
K301	64	M	3.5	Moderate	57.2	MT	×
K302	86	M	5.5	Poor	51.8	MT	○
K303	65	M	2.3	Moderate	41.8	WT	○
K304	76	F	1.0	Well	56.1	WT	○
K305	77	F	2.5	Mod	34.9	MT	○
K306	73	M	1.0	Well	56.1	WT	○
K307	72	M	2.3	Moderate	64.2	WT	×
K308	66	M	11.0	Moderate	66.1	WT	○
K309	72	M	6.8	Moderate	58.7	WT	○
K310	76	M	4.6	Well	101.3	MT	○
K311	68	F	9.0	Moderate	45.6	WT	×
K312	60	M	1.3	Poor	49.3	WT	×
K313	82	M	4.0	Moderate	34.7	WT	×
K314	83	F	4.5	Moderate	59.5	MT	×
K315	62	M	4.5	Moderate	57.7	WT	○
K316	75	M	4.0	Moderate	68.4	WT	○
K317	82	F	7.0	Poor	56.0	WT	○
K318	69	M	3.0	Moderate	58.8	MT	○
K319	63	M	4.0	Moderate	55.5	WT	○
K320	67	M	2.2	Well	60.3	MT	○
K321	59	M	2.2	Moderate	88.0	WT	○
K322	63	M	6.0	Moderate	13.4	WT	○
K323	69	M	3.3	Moderate	68.8	WT	○
K324	64	M	3.9	Moderate	56.7	WT	○
K325	66	M	3.0	Moderate	61.3	WT	×
K326	77	M	2.5	Poor	47.8	WT	×
K327	70	M	7.6	Moderate	31.9	WT	×
K328	56	M	6.1	Moderate	103.3	WT	×
K329	76	M	4.0	Moderate	56.1	WT	×
P318	58	M	10.6	Moderate	17.2	WT	×
P336	76	F	2.5	Moderate	10.2	WT	×
P328	57	F	4.2	Moderate	5.5	WT	×
P513	72	M	-	Moderate	38.9	WT	×
P520	69	M	5.0	Moderate	18.5	WT	×
P788	56	M	14.0	Moderate	42.7	WT	×
P958	71	M	17.0	Moderate	28.4	MT	×
P1335	64	M	2.5	Well	49.8	WT	×
P1342	68	M	2.2	Moderate	26.2	WT	×